13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Investor pitch & tips: What are early-stage investors looking for in the COVID-19 aftermaths?

Edition

Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.

Panel discussion

Investor pitch & tips: What are early-stage investors looking for in the COVID-19 aftermaths?

10 minutes investor’s pitch. Each investor talks 5 minutes about what they are looking for and then take the questions from the audience. The goal is to help identifying the right investor for the right project.
The pitches will be followed by a 30-minute moderated discussion to gather the investor panel insights on how to raise and secure funds in the current context. How has COVID-19 pandemic influenced investors and what is the impact on early-stage pattern of investment? To what extent is the early-stage investment in Biotech and Medtech affected? What are the opportunities to beat the funding odds during COVID-19?

The panel will feature feedback from early-stage investors, discussing key figures and recent experiences as well as guidance for start-ups dealing with this additional funding challenge.

Rodrigo Mallo Leiva

Partner
United Kingdom
IndieBio – SOSV

Irene Fialka

CEO
Austria
INiTS

Bert-Arjan Millenaar

Founder & CEO
The Netherlands
NLC

Sascha Berger

Partner
Germany
TVM Capital

Michèle Ollier

Co-Founder and Partner
Switzerland
Medicxi Ventures
Scroll to Top
  • No products in the cart.